<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-title>BMC Cancer</journal-title><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17140447</article-id><article-id pub-id-type="pmc">1693923</article-id><article-id pub-id-type="publisher-id">1471-2407-6-273</article-id><article-id pub-id-type="doi">10.1186/1471-2407-6-273</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Kilbreath</surname><given-names>Sharon L</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>s.kilbreath@usyd.edu.au</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Refshauge</surname><given-names>Kathryn M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>k.refshauge@usyd.edu.au</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Beith</surname><given-names>Jane M</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Jane.Beith@cs.nsw.gov.au</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Ward</surname><given-names>Leigh C</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>l.ward@uq.edu.au</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Simpson</surname><given-names>Judy M</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>judys@health.usyd.edu.au</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Hansen</surname><given-names>Ross D</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>hansenr@med.usyd.edu.au</email></contrib></contrib-group><aff id="I1"><label>1</label>Faculty of Health Sciences, University of Sydney, Sydney, Australia</aff><aff id="I2"><label>2</label>Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia</aff><aff id="I3"><label>3</label>School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Australia</aff><aff id="I4"><label>4</label>School of Public Health, University of Sydney, Sydney, Australia</aff><aff id="I5"><label>5</label>Gastrointestinal Investigation Unit, Royal North Shore Hospital, Sydney, Australia</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>1</day><month>12</month><year>2006</year></pub-date><volume>6</volume><fpage>273</fpage><lpage>273</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/6/273"></ext-link><history><date date-type="received"><day>8</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>1</day><month>12</month><year>2006</year></date></history><permissions><copyright-statement>Copyright © 2006 Kilbreath et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Kilbreath et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="3886" xml_f="3896" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3907" xml_f="4416" txt_i="22" txt_f="531">Currently 1 in 11 women over the age of 60 in Australia are diagnosed with breast cancer. Following treatment, most breast cancer patients are left with shoulder and arm impairments which can impact significantly on quality of life and interfere substantially with activities of daily living. The primary aim of the proposed study is to determine whether upper limb impairments can be prevented by undertaking an exercise program of prolonged stretching and resistance training, commencing soon after surgery.</offsets></p></sec><sec><title><offsets xml_i="4438" xml_f="4452" txt_i="533" txt_f="547">Methods/design</offsets></title><p><offsets xml_i="4463" xml_f="5393" txt_i="548" txt_f="1478">We will recruit 180 women who have had surgery for early stage breast cancer to a multicenter single-blind randomized controlled trial. At 4 weeks post surgery, women will be randomly assigned to either an exercise group or a usual care (control) group. Women allocated to the exercise group will perform exercises daily, and will be supervised once a week for 8 weeks. At the end of the 8 weeks, women will be given a home-based training program to continue indefinitely. Women in the usual care group will receive the same care as is now typically provided, i.e. a visit by the physiotherapist and occupational therapist while an inpatient, and receipt of pamphlets. All subjects will be assessed at baseline, 8 weeks, and 6 months later. The primary measure is arm symptoms, derived from a breast cancer specific questionnaire (BR23). In addition, range of motion, strength, swelling, pain and quality of life will be assessed.</offsets></p></sec><sec><title><offsets xml_i="5415" xml_f="5425" txt_i="1480" txt_f="1490">Discussion</offsets></title><p><offsets xml_i="5436" xml_f="5801" txt_i="1491" txt_f="1856">This study will determine whether exercise commencing soon after surgery can prevent secondary problems associated with treatment of breast cancer, and will thus provide the basis for successful rehabilitation and reduction in ongoing problems and health care use. Additionally, it will identify whether strengthening exercises reduce the incidence of arm swelling.</offsets></p></sec><sec><title><offsets xml_i="5823" xml_f="5841" txt_i="1858" txt_f="1876">Trial Registration</offsets></title><p><offsets xml_i="5852" xml_f="5962" txt_i="1877" txt_f="1987">The protocol for this study is registered with the Australian Clinical Trials Registry (ACTRN012606000050550).</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="6024" xml_f="6034" txt_i="1996" txt_f="2006">Background</offsets></title><p><offsets xml_i="6045" xml_f="6171" txt_i="2007" txt_f="2133">Upper limb arm morbidity resulting from treatment for early breast cancer is a common sequela of treatment for breast cancer [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="6202" xml_f="6203" txt_i="2133" txt_f="2134">1</offsets></xref><offsets xml_i="6210" xml_f="6386" txt_i="2134" txt_f="2310">]. In a study of 644 older women treated for breast cancer, 54% reported a decline in upper body function compared to 10% in the control group who had not undergone treatment [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6417" xml_f="6418" txt_i="2310" txt_f="2311">2</offsets></xref><offsets xml_i="6425" xml_f="6470" txt_i="2311" txt_f="2356">]. Based on reports of upper limb morbidity [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6501" xml_f="6502" txt_i="2356" txt_f="2357">2</offsets></xref><offsets xml_i="6509" xml_f="6864" txt_i="2357" txt_f="2712">], current practices do not adequately address or prevent the impairments that may arise from management of the tumour. While the long-term morbidity is well documented, little evidence is available to inform clinicians in the best way to minimise and prevent these upper limb problems. As upper limb morbidity is associated with reduced quality of life [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="6895" xml_f="6896" txt_i="2712" txt_f="2713">3</offsets></xref><offsets xml_i="6903" xml_f="6904" txt_i="2713" txt_f="2714">,</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="6935" xml_f="6936" txt_i="2714" txt_f="2715">4</offsets></xref><offsets xml_i="6943" xml_f="7048" txt_i="2715" txt_f="2820">], particularly emotional, social and physical functioning aspects, as well as body image and lifestyle [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="7079" xml_f="7080" txt_i="2820" txt_f="2821">5</offsets></xref><offsets xml_i="7087" xml_f="7157" txt_i="2821" txt_f="2891">], it is important that effective preventive strategies be identified.</offsets></p><p><offsets xml_i="7164" xml_f="7316" txt_i="2892" txt_f="3044">The potential benefits of progressive resistance training soon after surgery has not been investigated even though many women report shoulder weakness [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="7347" xml_f="7348" txt_i="3044" txt_f="3045">4</offsets></xref><offsets xml_i="7355" xml_f="7356" txt_i="3045" txt_f="3046">,</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7387" xml_f="7388" txt_i="3046" txt_f="3047">6</offsets></xref><offsets xml_i="7395" xml_f="7396" txt_i="3047" txt_f="3048">-</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="7427" xml_f="7428" txt_i="3048" txt_f="3049">8</offsets></xref><offsets xml_i="7435" xml_f="7514" txt_i="3049" txt_f="3128">]. It is commonly believed that vigorous arm exercises will induce lymphedema [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="7545" xml_f="7546" txt_i="3128" txt_f="3129">9</offsets></xref><offsets xml_i="7553" xml_f="7618" txt_i="3129" txt_f="3194">] although evidence from our pilot study challenges this belief [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="7650" xml_f="7652" txt_i="3194" txt_f="3196">10</offsets></xref><offsets xml_i="7659" xml_f="7872" txt_i="3196" txt_f="3409">]. To date, no studies have investigated the use of resistance training early after surgery, although this may be the stage at which exercises have the greatest effect in preventing lymphedema and muscle weakness.</offsets></p><p><offsets xml_i="7879" xml_f="8015" txt_i="3410" txt_f="3546">Stretching is advocated following breast cancer surgery; however, given the reports of reduced range and consequent shoulder stiffness [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="8046" xml_f="8047" txt_i="3546" txt_f="3547">4</offsets></xref><offsets xml_i="8054" xml_f="8055" txt_i="3547" txt_f="3548">,</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="8086" xml_f="8087" txt_i="3548" txt_f="3549">6</offsets></xref><offsets xml_i="8094" xml_f="8095" txt_i="3549" txt_f="3550">-</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="8126" xml_f="8127" txt_i="3550" txt_f="3551">8</offsets></xref><offsets xml_i="8134" xml_f="8135" txt_i="3551" txt_f="3552">,</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="8167" xml_f="8169" txt_i="3552" txt_f="3554">11</offsets></xref><offsets xml_i="8176" xml_f="8377" txt_i="3554" txt_f="3755">], the stretching protocols do not appear to have been performed in a particularly effective way. Little detail of the actual exercises has been provided in the available randomized controlled trials [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="8409" xml_f="8411" txt_i="3755" txt_f="3757">12</offsets></xref><offsets xml_i="8418" xml_f="8549" txt_i="3757" txt_f="3888">]. In several studies, participants were seen by a physiotherapist but details of the exercises, including duration, were omitted [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="8581" xml_f="8583" txt_i="3888" txt_f="3890">12</offsets></xref><offsets xml_i="8590" xml_f="8719" txt_i="3890" txt_f="4019">]. Evidence from animal models suggests that adverse physiological adaptations can be prevented with prolonged daily stretching [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="8751" xml_f="8753" txt_i="4019" txt_f="4021">13</offsets></xref><offsets xml_i="8760" xml_f="8919" txt_i="4021" txt_f="4180">] and prolonged stretches at the shoulder have been shown to be highly effective in other patient populations at risk of developing significant loss of range [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="8951" xml_f="8953" txt_i="4180" txt_f="4182">14</offsets></xref><offsets xml_i="8960" xml_f="9082" txt_i="4182" txt_f="4304">]. Thus, prolonged stretches may decrease the loss of range and joint stiffness consequent to treatment for breast cancer.</offsets></p><p><offsets xml_i="9089" xml_f="9616" txt_i="4305" txt_f="4832">We therefore aim to conduct a randomized controlled trial to determine whether an intensive exercise program, commencing 4 weeks after breast cancer surgery, prevents weakness, pain, swelling, and loss of range in the upper limb. We will also determine whether quality of life (as measured by arm symptoms) improves for women who undertake an intensive exercise program early after breast cancer surgery. Lastly, we will determine the effect of resistance training soon after surgery on the short-term occurrence of lymphedema.</offsets></p></sec><sec><title><offsets xml_i="9638" xml_f="9652" txt_i="4834" txt_f="4848">Methods/design</offsets></title><sec><title><offsets xml_i="9672" xml_f="9678" txt_i="4849" txt_f="4855">Design</offsets></title><p><offsets xml_i="9689" xml_f="10197" txt_i="4856" txt_f="5364">To determine the efficacy of an intensive upper limb exercise program for women soon after breast cancer surgery, we will conduct a multi-center, single-blind randomised controlled trial. Women will be recruited from 3 large hospitals with breast cancer oncology services in Sydney, Australia. Breast Cancer Nurses will inform potential participants about the study when they visit the patient after surgery. To provide sufficient time for the wound to heal, women will enter the study 4 weeks after surgery.</offsets></p><p><offsets xml_i="10204" xml_f="10432" txt_i="5365" txt_f="5593">A record will be kept of the number of invitations to participate, the number of potential participants who volunteer to participate, and the number of screened patients who are ineligible and the reason for their ineligibility.</offsets></p><p><offsets xml_i="10439" xml_f="10604" txt_i="5594" txt_f="5759">Ethical approval has been received from the participating hospitals as well as from The University of Sydney. All participants will provide written informed consent.</offsets></p></sec><sec><title><offsets xml_i="10626" xml_f="10638" txt_i="5761" txt_f="5773">Participants</offsets></title><p><offsets xml_i="10649" xml_f="11025" txt_i="5774" txt_f="6150">Women will be included in the study if they: have undergone a breast cancer intervention that included surgery to the axilla; can attend for treatment and follow-up; understand English and consent to participate and be randomised to either treatment group. Women scheduled for adjunct treatments including radiotherapy, chemotherapy and breast reconstruction will be included.</offsets></p><p><offsets xml_i="11032" xml_f="11654" txt_i="6151" txt_f="6773">Women will be excluded if they have not had surgery to the axilla or have undergone bilateral operations, present with infection at the baseline measurement or have received previous treatment for breast cancer or have metastatic disease. In addition, women will be excluded if they have sustained a fracture, undergone surgery in the upper limbs, or suffered any neurological deficit or other injury to either upper limb that may interfere with the test procedures. Lastly, women will be excluded if they undergo breast reconstruction and as a consequence, their specialist has indicated that they are not to participate.</offsets></p></sec><sec><title><offsets xml_i="11676" xml_f="11689" txt_i="6775" txt_f="6788">Randomization</offsets></title><p><offsets xml_i="11700" xml_f="12304" txt_i="6789" txt_f="7393">An investigator who has no direct contact with the subjects will be responsible for generating the randomisation list. Randomisation will be stratified by whether women receive axillary node resection or sentinel node biopsy. The randomisation list will be used to prepare numbered opaque envelopes with the group allocation sealed inside by a person not involved in the study. Immediately after baseline assessment, women will be randomly allocated to either the usual care or exercise group. The protocol for this study is registered with the Australian Clinical Trials Registry (ACTRN012606000050550).</offsets></p></sec><sec><title><offsets xml_i="12326" xml_f="12339" txt_i="7395" txt_f="7408">Interventions</offsets></title><sec><title><offsets xml_i="12359" xml_f="12369" txt_i="7409" txt_f="7419">Usual care</offsets></title><p><offsets xml_i="12380" xml_f="13019" txt_i="7420" txt_f="8059">Women will receive the same care as is now provided in the three participating hospitals. Women are typically admitted on the day of surgery and are discharged 2 to 7 days after surgery. While in hospital, they are seen by a physiotherapist who reviews gentle shoulder exercises which are outlined in a pamphlet. The active assisted shoulder exercises are for shoulder protraction, elevation and abduction. In addition, women are seen by an occupational therapist who discusses issues related to prevention of lymphedema. Women are not followed by either the physiotherapist or the occupational therapist after discharge from the hospital.</offsets></p><p><offsets xml_i="13026" xml_f="13340" txt_i="8060" txt_f="8374">Women in the Usual Care group will not be given a home program of exercises, apart from those described in the pamphlet. To control for attention from the research assistant, they will meet with the research assistant fortnightly at which time their arm will be assessed with multifrequency bioimpedance analysis [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="13372" xml_f="13374" txt_i="8374" txt_f="8376">15</offsets></xref><offsets xml_i="13381" xml_f="13485" txt_i="8376" txt_f="8480">] for the development of lymphedema, but no specific advice will be given about exercise and management.</offsets></p></sec><sec><title><offsets xml_i="13507" xml_f="13521" txt_i="8482" txt_f="8496">Exercise group</offsets></title><p><offsets xml_i="13532" xml_f="13781" txt_i="8497" txt_f="8746">Commencing Week 4 following surgery, women will attend 8 weekly exercise sessions comprising stretching exercises and resistance training, and will commence a daily home program of similar exercises. We have used these exercises in our pilot study [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="13813" xml_f="13815" txt_i="8746" txt_f="8748">10</offsets></xref><offsets xml_i="13822" xml_f="13853" txt_i="8748" txt_f="8779">], and they are well tolerated.</offsets></p><p><offsets xml_i="13860" xml_f="14980" txt_i="8780" txt_f="9894">Each week, there will be a supervised weekly session at which women will perform the shoulder exercises targeting the muscles and shoulder movements likely to be at risk. Stretches will consist of prolonged holds of at least 5 minutes duration. The stretches are performed in supine and are undertaken for the shoulder extensors, and for pectoralis major and minor muscles. For women unable to achieve &gt;90 deg forward flexion, shoulder extension and abduction stretches will be performed whilst seated. For both stretches, the arm will be elevated in the appropriate direction and supported on pillows; the aim of these stretches is to provide a comfortable stretch in the region of the participant's axilla. Each of these stretches will also be held initially for 5 minutes and progressed up to 20 min. Once shoulder flexion &gt;90 deg is achieved, the participant will undertake the stretches in supine. The muscles targeted for resistance training include the shoulder flexors, abductors, external rotators and horizontal flexors. For strength training, the resistance will be determined by the Borg Effort Scale [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="15012" xml_f="15014" txt_i="9894" txt_f="9896">16</offsets></xref><offsets xml_i="15021" xml_f="15124" txt_i="9896" txt_f="9999">] and provided by free weights. Each week, the exercises will be monitored, and progressed as required.</offsets></p><p><offsets xml_i="15131" xml_f="15795" txt_i="10000" txt_f="10664">In addition to the weekly supervised sessions, women will perform a daily home program. The program will consist of i) a daily stretching program and ii) a strengthening program undertaken on alternate days. The stretching program will be the same as that undertaken at the weekly supervised session. For the strengthening program, the same muscles will be trained as in the weekly supervised sessions but rather than free weights, the resistance will be provided by theraband. Participants will be instructed to perform two sets of 8 – 12 repetitions for each exercise. Participants will be instructed to work at a target of 15 ('Hard') on the Borg Effort Scale [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="15827" xml_f="15829" txt_i="10664" txt_f="10666">16</offsets></xref><offsets xml_i="15836" xml_f="15837" txt_i="10666" txt_f="10667">]</offsets></p><p><offsets xml_i="15844" xml_f="16165" txt_i="10668" txt_f="10989">At the conclusion of the program, women will be encouraged to continue the home program. A compliance diary will be provided to record the number of times each exercise was performed each day. In addition, women in both groups will be asked to record any other treatments that they have received the dose, and the effect.</offsets></p></sec></sec><sec><title><offsets xml_i="16193" xml_f="16204" txt_i="10992" txt_f="11003">Measurement</offsets></title><p><offsets xml_i="16215" xml_f="16830" txt_i="11004" txt_f="11619">All measurements will be undertaken by a research assistant blinded to the group to which women were allocated. Variables will be measured before randomization, at 8 weeks (the end of the intervention phase) and then at 6 months to determine the effect of the intervention on physical and psychosocial outcomes. In addition, information about the breast cancer treatment regimen, pathology report, age, weight, and previous shoulder pathology will be obtained from the patient's medical record at the baseline assessment. Occurrence of side-effects and adverse events will be evaluated at each measurement occasion.</offsets></p><p><offsets xml_i="16837" xml_f="17601" txt_i="11620" txt_f="12384">The primary outcome measure for treatment efficacy is arm symptoms on the operated side, derived from 3 items of the Breast Module (BR23). The BR23 is a 23-item survey specific to women with breast cancer. The 3 selected items ask whether in the past week the woman has had pain in her arm or shoulder, a swollen arm or hand, and whether it was difficult to raise or move her arm sideways. For each question, there are 4 possible responses, ranging from 'not at all' to 'very much'. The raw scores for these questions are summed and then subjected to linear transformation to provide an overall score, with a maximum of 100. A high score indicates a high level of symptoms. The primary endpoint for the trial is change in primary outcome from baseline to 6 months.</offsets></p><p><offsets xml_i="17608" xml_f="17704" txt_i="12385" txt_f="12481">Secondary outcomes include other aspects of quality of life and measures of physical impairment.</offsets></p><p><offsets xml_i="17711" xml_f="18205" txt_i="12482" txt_f="12976">Quality of life will be measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Version 3 (QLQ-C30) and the Breast Module (BR23). These surveys are specific to cancer patients and comprise a global health status/quality of life scale, as well as functional and symptom scales. These questionnaires are reliable, valid and sensitive to change and able to distinguish patients in different disease stages and with different performance status [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="18237" xml_f="18239" txt_i="12976" txt_f="12978">17</offsets></xref><offsets xml_i="18246" xml_f="18247" txt_i="12978" txt_f="12979">-</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="18279" xml_f="18281" txt_i="12979" txt_f="12981">19</offsets></xref><offsets xml_i="18288" xml_f="18290" txt_i="12981" txt_f="12983">].</offsets></p><p><offsets xml_i="18297" xml_f="18825" txt_i="12984" txt_f="13512">Shoulder range of motion will be assessed using an inclinometer and a standardised protocol will be followed to minimise compensatory movements. Passive forward flexion, external rotation and horizontal abduction at the shoulder will be assessed in a supine position and with gravity as the standardised force. Active abduction will be assessed in the sitting position. Each arm will be measured separately. Pain at the end of the passive range of each movement will be measured using a standardised 10 cm visual analogue scale.</offsets></p><p><offsets xml_i="18832" xml_f="19184" txt_i="13513" txt_f="13865">Maximal isometric shoulder strength will be measured objectively with a dynamometer using a standardised protocol. The arm will be positioned at 90 degrees elevation to assess forward flexion, abduction, and horizontal abduction and adduction. Movement in these planes has been selected as it has been shown to be weak following breast cancer surgery [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="19216" xml_f="19218" txt_i="13865" txt_f="13867">20</offsets></xref><offsets xml_i="19225" xml_f="19226" txt_i="13867" txt_f="13868">,</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="19258" xml_f="19260" txt_i="13868" txt_f="13870">21</offsets></xref><offsets xml_i="19267" xml_f="19436" txt_i="13870" txt_f="14039">]. For each direction, women will perform 3 maximum voluntary contractions, and the highest of the three attempts will be recorded. Each arm will be measured separately.</offsets></p><p><offsets xml_i="19443" xml_f="19620" txt_i="14040" txt_f="14217">The presence of lymphedema will be measured non-invasively using multiple frequency bio-impedance analysis. This analysis identifies early changes in tissue fluid accumulation [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="19652" xml_f="19654" txt_i="14217" txt_f="14219">22</offsets></xref><offsets xml_i="19661" xml_f="19867" txt_i="14219" txt_f="14422">] and is substantially more sensitive than total limb volume measurements in detecting changes in extracellular fluid volume. It has an extremely low (&lt;1 %) false-positive rate for detecting lymphedema [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="19899" xml_f="19901" txt_i="14422" txt_f="14424">22</offsets></xref><offsets xml_i="19908" xml_f="20037" txt_i="14424" txt_f="14553">]. In addition, circumference measures at multiple sites on each arm will be obtained using a standardised measurement technique.</offsets></p><p><offsets xml_i="20044" xml_f="20236" txt_i="14554" txt_f="14746">All women will be requested to record use of resources (number and type of health care contacts, medication use, adjunct treatments) during the trial period and the effect of these treatments.</offsets></p><p><offsets xml_i="20243" xml_f="20465" txt_i="14747" txt_f="14969">The occurrence of lymphedema, regardless of treatment group allocation, is considered an 'adverse' event. If lymphedema develops, women will be referred to the Breast Cancer Nurse for referral to an appropriate specialist.</offsets></p></sec><sec><title><offsets xml_i="20487" xml_f="20500" txt_i="14971" txt_f="14984">Data analysis</offsets></title><sec><title><offsets xml_i="20520" xml_f="20544" txt_i="14985" txt_f="15009">Sample size calculations</offsets></title><p><offsets xml_i="20555" xml_f="21063" txt_i="15010" txt_f="15518">We will recruit 180 women, 90 to each of the two treatment groups. This will give 80% power to detect as significant at the 2-sided 5% significance level a difference of 12 points (out of 100) for arm symptoms derived from the BR23, based on our pilot data standard deviation of 25. In addition, we have allowed for 20% mortality and loss to follow-up. Based on our pilot data, we will also be able to detect at least 10° difference in range of motion at the shoulder and 5 N difference in shoulder strength.</offsets></p></sec><sec><title><offsets xml_i="21085" xml_f="21105" txt_i="15520" txt_f="15540">Statistical analysis</offsets></title><p><offsets xml_i="21116" xml_f="21447" txt_i="15541" txt_f="15872">Treatment group will be coded to enable blinded analysis, which will be by "intention-to-treat". For the primary outcome measure, the change from baseline score for arm symptoms on the operated side derived from the BR23 will be determined. The mean change will be compared between the two groups using Student's two-sample t-test.</offsets></p><p><offsets xml_i="21454" xml_f="21815" txt_i="15873" txt_f="16234">Our secondary analyses will examine the effect of adjusting for the stratifying factor (type of surgery) or any important prognostic factors that show a clinically important imbalance between groups. This will be done using multiple linear regression, with the baseline arm symptoms score as a covariate and the final arm symptoms score as the outcome variable.</offsets></p><p><offsets xml_i="21822" xml_f="22390" txt_i="16235" txt_f="16803">For measures of strength, range of motion, and lymphedema, the difference between the operated and non-operated side will be determined. These differences at 6 months will be compared using a two-sample t-test or distribution-free equivalent, as appropriate. For other aspects of the quality of life score, the mean changes from baseline will be compared between the two groups using Student's two-sample t-test. As for the primary outcome, multiple regression analyses will be used for all secondary variables to adjust for covariates, including baseline differences.</offsets></p></sec></sec></sec><sec><title><offsets xml_i="22424" xml_f="22434" txt_i="16807" txt_f="16817">Discussion</offsets></title><p><offsets xml_i="22445" xml_f="22595" txt_i="16818" txt_f="16968">With more than 85% of women treated for breast cancer surviving over 5 years, the long term sequelae of treatment have become increasingly important [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="22627" xml_f="22629" txt_i="16968" txt_f="16970">23</offsets></xref><offsets xml_i="22636" xml_f="22717" txt_i="16970" txt_f="17051">]. Most women are left with long-term symptoms affecting their arm and shoulder [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="22749" xml_f="22751" txt_i="17051" txt_f="17053">11</offsets></xref><offsets xml_i="22758" xml_f="23155" txt_i="17053" txt_f="17450">]. Changes to surgical management for identification of the tumour have reduced the severity of long-term sequelae but have not prevented them from occurring. In fact, of women who undergo a sentinel node biopsy, the 30% who then have an axillary node dissection in a two-step axillary operation are at greater risk of developing arm morbidity than women who only undergo axillary node clearance [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="23186" xml_f="23187" txt_i="17450" txt_f="17451">5</offsets></xref><offsets xml_i="23194" xml_f="23195" txt_i="17451" txt_f="17452">,</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="23227" xml_f="23229" txt_i="17452" txt_f="17454">24</offsets></xref><offsets xml_i="23236" xml_f="23391" txt_i="17454" txt_f="17609">]. As long-term symptoms compound the physical and psychological trauma of the disease, preventing the resumption of a normal physical and emotional life [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="23422" xml_f="23423" txt_i="17609" txt_f="17610">3</offsets></xref><offsets xml_i="23430" xml_f="23431" txt_i="17610" txt_f="17611">,</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="23462" xml_f="23463" txt_i="17611" txt_f="17612">4</offsets></xref><offsets xml_i="23470" xml_f="23517" txt_i="17612" txt_f="17659">], it is important to prevent their occurrence.</offsets></p><p><offsets xml_i="23524" xml_f="23605" txt_i="17660" txt_f="17741">This randomized controlled trial was designed using features that minimise bias [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="23637" xml_f="23639" txt_i="17741" txt_f="17743">25</offsets></xref><offsets xml_i="23646" xml_f="24122" txt_i="17743" txt_f="18219">]. For example, we have included true randomisation, concealed allocation, blinded measurement and data analysis, and analysis by intention-to-treat. The nature of the treatments and outcomes precludes blinding of treatment. However, bias will be minimised by blinding subjects to the experimental hypotheses. Thus, the findings from this study will demonstrate the efficacy of an early intervention program comprising progressive resistance training and prolonged stretching.</offsets></p><p><offsets xml_i="24129" xml_f="24389" txt_i="18220" txt_f="18480">The present proposal is to apply early, intensive exercise for prevention of side-effects from surgery. The findings from this study will enable the formulation of evidence-based data on stretching and resistance training early following breast cancer surgery.</offsets></p></sec><sec><title><offsets xml_i="24411" xml_f="24430" txt_i="18482" txt_f="18501">Competing interests</offsets></title><p><offsets xml_i="24441" xml_f="24501" txt_i="18502" txt_f="18562">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="24523" xml_f="24545" txt_i="18564" txt_f="18586">Authors' contributions</offsets></title><p><offsets xml_i="24556" xml_f="24782" txt_i="18587" txt_f="18813">SK, KR and JB conceived the project. All authors contributed to the design of the trial and the procurement of funding. SK drafted the manuscript and all authors have contributed to the manuscript and have read the manuscript.</offsets></p></sec><sec><title><offsets xml_i="24804" xml_f="24827" txt_i="18815" txt_f="18838">Pre-publication history</offsets></title><p><offsets xml_i="24838" xml_f="24902" txt_i="18839" txt_f="18903">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/6/273/prepub"></ext-link></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This trial is funded by Cancer Council NSW (Reference Number: RG 06-04).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rietman</surname><given-names>JS</given-names></name><name><surname>Dijkstra</surname><given-names>PU</given-names></name><name><surname>Hoekstra</surname><given-names>HJ</given-names></name><name><surname>Eisma</surname><given-names>WH</given-names></name><name><surname>Szabo</surname><given-names>BG</given-names></name><name><surname>Groothoff</surname><given-names>JW</given-names></name><name><surname>Geertzen</surname><given-names>JH</given-names></name></person-group><article-title>Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review</article-title><source>Eur J Surg Oncol</source><year>2003</year><volume>29</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">12657232</pub-id><pub-id pub-id-type="doi">10.1053/ejso.2002.1403</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westrup</surname><given-names>JL</given-names></name><name><surname>Lash</surname><given-names>TL</given-names></name><name><surname>Thwin</surname><given-names>SS</given-names></name><name><surname>Silliman</surname><given-names>RA</given-names></name></person-group><article-title>Risk of decline in upper-body function and symptoms among older breast cancer patients</article-title><source>J Gen Intern Med</source><year>2006</year><volume>21</volume><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">16686807</pub-id><pub-id pub-id-type="doi">10.1111/j.1525-1497.2006.00384.x</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>LG</given-names></name><name><surname>Nash</surname><given-names>R</given-names></name><name><surname>Round</surname><given-names>T</given-names></name><name><surname>Newman</surname><given-names>B</given-names></name></person-group><article-title>Perceptions of upper-body problems during recovery from breast cancer treatment</article-title><source>Support Care Cancer</source><year>2004</year><volume>12</volume><fpage>106</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">14593521</pub-id><pub-id pub-id-type="doi">10.1007/s00520-003-0554-5</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maunsell</surname><given-names>E</given-names></name><name><surname>Brisson</surname><given-names>J</given-names></name><name><surname>Deschenes</surname><given-names>L</given-names></name></person-group><article-title>Arm problems and psychological distress after surgery for breast cancer</article-title><source>Can J Surg</source><year>1993</year><volume>36</volume><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">8370012</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>J</given-names></name><name><surname>Kerr</surname><given-names>J</given-names></name><name><surname>Schlesinger-Raab</surname><given-names>A</given-names></name><name><surname>Sauer</surname><given-names>H</given-names></name><name><surname>Holzel</surname><given-names>D</given-names></name><name><surname>Eckel</surname><given-names>R</given-names></name></person-group><article-title>Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study</article-title><source>Breast J</source><year>2004</year><volume>10</volume><fpage>223</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">15125749</pub-id><pub-id pub-id-type="doi">10.1111/j.1075-122X.2004.21323.x</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivens</surname><given-names>D</given-names></name><name><surname>Hoe</surname><given-names>AL</given-names></name><name><surname>Podd</surname><given-names>TJ</given-names></name><name><surname>Hamilton</surname><given-names>CR</given-names></name><name><surname>Taylor</surname><given-names>I</given-names></name><name><surname>Royle</surname><given-names>GT</given-names></name></person-group><article-title>Assessment of morbidity from complete axillary dissection</article-title><source>Br J Cancer</source><year>1992</year><volume>66</volume><fpage>136</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">1637663</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kakuda</surname><given-names>JT</given-names></name><name><surname>Stuntz</surname><given-names>M</given-names></name><name><surname>Trivedi</surname><given-names>V</given-names></name><name><surname>Klein</surname><given-names>SR</given-names></name><name><surname>Vargas</surname><given-names>HI</given-names></name></person-group><article-title>Objective assessment of axillary morbidity in breast cancer treatment</article-title><source>Am Surg</source><year>1999</year><volume>65</volume><fpage>995</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">10515551</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>MF</given-names></name><name><surname>Voogd</surname><given-names>AC</given-names></name><name><surname>Balder</surname><given-names>W</given-names></name><name><surname>Klinkenbijl</surname><given-names>JH</given-names></name><name><surname>Roukema</surname><given-names>JA</given-names></name></person-group><article-title>Early and late morbidity associated with axillary levels I-III dissection in breast cancer</article-title><source>J Surg Oncol</source><year>2002</year><volume>79 </volume><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">11870664</pub-id><pub-id pub-id-type="doi">10.1002/jso.10061</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>SR</given-names></name><name><surname>Hugi</surname><given-names>MR</given-names></name><name><surname>Olivotto</surname><given-names>IA</given-names></name><name><surname>Levine</surname><given-names>M</given-names></name></person-group><article-title>Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema</article-title><source>CMAJ</source><year>2001</year><volume>164</volume><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">11332311</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kilbreath</surname><given-names>SL</given-names></name><name><surname>Refshauge</surname><given-names>KM</given-names></name><name><surname>Beith</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name></person-group><article-title>Resistance and stretching shoulder exercises early following axillary surgery for breast cancer,</article-title><source>Rehabilitation Oncology</source><year>2006</year><volume>24</volume><fpage>9 </fpage><lpage>14</lpage></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCredie</surname><given-names>MRE</given-names></name><name><surname>Dite</surname><given-names>GS</given-names></name><name><surname>Porter</surname><given-names>L</given-names></name><name><surname>Maskiell</surname><given-names>J</given-names></name><name><surname>Giles</surname><given-names>GG</given-names></name><name><surname>Phillips</surname><given-names>KA</given-names></name><name><surname>Redman</surname><given-names>S</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name></person-group><article-title>Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study</article-title><source>Breast</source><year>2001</year><volume>10</volume><fpage>515</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">14965632</pub-id><pub-id pub-id-type="doi">10.1054/brst.2000.0291</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shamley</surname><given-names>DR</given-names></name><name><surname>Barker</surname><given-names>K</given-names></name><name><surname>Simonite</surname><given-names>V</given-names></name><name><surname>Beardshaw</surname><given-names>A</given-names></name></person-group><article-title>Delayed versus immediate exercises following surgery for breast cancer: a systematic review</article-title><source>Breast Cancer Res Treat</source><year>2005</year><volume>90</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">15830140</pub-id><pub-id pub-id-type="doi">10.1007/s10549-004-4727-9</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>PE</given-names></name></person-group><article-title>Use of intermittent stretch in the prevention of serial sarcomere loss in immobilised muscle</article-title><source>Ann Rheum Dis</source><year>1990</year><volume>49</volume><fpage>316</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">2344211</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ada</surname><given-names>L</given-names></name><name><surname>Goddard</surname><given-names>E</given-names></name><name><surname>McCully</surname><given-names>J</given-names></name><name><surname>Stavrinos</surname><given-names>T</given-names></name><name><surname>Bampton</surname><given-names>J</given-names></name></person-group><article-title>Thirty minutes of positioning reduces the development of shoulder external rotation contracture after stroke: a randomized controlled trial.</article-title><source>Arch Phys Med Rehabil</source><year>2005</year><volume>86</volume><fpage>230</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">15706548</pub-id><pub-id pub-id-type="doi">10.1016/j.apmr.2004.02.031</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornish</surname><given-names>BH</given-names></name><name><surname>Bunce</surname><given-names>IH</given-names></name><name><surname>Ward</surname><given-names>LC</given-names></name><name><surname>Jones</surname><given-names>LC</given-names></name><name><surname>Thomas</surname><given-names>BJ</given-names></name></person-group><article-title>Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes</article-title><source>Breast Cancer Res Treat</source><year>1996</year><volume>38</volume><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">8861835</pub-id><pub-id pub-id-type="doi">10.1007/BF01806671</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>BJ</given-names></name><name><surname>Borg</surname><given-names>GA</given-names></name><name><surname>Jacobs</surname><given-names>I</given-names></name><name><surname>Ceci</surname><given-names>R</given-names></name><name><surname>Kaiser</surname><given-names>P</given-names></name></person-group><article-title>A category-ratio perceived exertion scale: relationship to blood and muscle lactates and heart rate</article-title><source>Med Sci Sports Exerc</source><year>1983</year><volume>15</volume><fpage>523</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">6656563</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aaronson</surname><given-names>NK</given-names></name><name><surname>Ahmedzai</surname><given-names>S</given-names></name><name><surname>Bergman</surname><given-names>B</given-names></name><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Cull</surname><given-names>A</given-names></name><name><surname>Duez</surname><given-names>NJ</given-names></name><name><surname>Filiberti</surname><given-names>A</given-names></name><name><surname>Flechtner</surname><given-names>H</given-names></name><name><surname>Fleishman</surname><given-names>SB</given-names></name><name><surname>de Haes</surname><given-names>JC</given-names></name><etal></etal></person-group><article-title>The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology</article-title><source>J Natl Cancer Inst</source><year>1993</year><volume>85</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">8433390</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hjermstad</surname><given-names>MJ</given-names></name><name><surname>Fossa</surname><given-names>SD</given-names></name><name><surname>Bjordal</surname><given-names>K</given-names></name><name><surname>Kaasa</surname><given-names>S</given-names></name></person-group><article-title>Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire</article-title><source>J Clin Oncol</source><year>1995</year><volume>13</volume><fpage>1249</fpage><lpage>1254</lpage><pub-id pub-id-type="pmid">7738629</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sprangers</surname><given-names>MA</given-names></name><name><surname>Groenvold</surname><given-names>M</given-names></name><name><surname>Arraras</surname><given-names>JI</given-names></name><name><surname>Franklin</surname><given-names>J</given-names></name><name><surname>te Velde</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Franzini</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>de Haes</surname><given-names>HC</given-names></name><name><surname>Hopwood</surname><given-names>P</given-names></name><name><surname>Cull</surname><given-names>A</given-names></name><name><surname>Aaronson</surname><given-names>NK</given-names></name></person-group><article-title>The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study</article-title><source>J Clin Oncol</source><year>1996</year><volume>14</volume><fpage>2756</fpage><lpage>2768</lpage><pub-id pub-id-type="pmid">8874337</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>K</given-names></name><name><surname>Ingvar</surname><given-names>C</given-names></name><name><surname>Albertsson</surname><given-names>M</given-names></name><name><surname>Ekdahl</surname><given-names>C</given-names></name></person-group><article-title>Arm lymphoedema, shoulder mobility and muscle strength after breast cancer treatment -- a prospective 2-year study</article-title><source>Adv Physiother</source><year>2001</year><volume>3</volume><fpage>55</fpage><lpage>66</lpage></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikkanen</surname><given-names>TA</given-names></name><name><surname>Vanharanta</surname><given-names>H</given-names></name><name><surname>Helenius-Reunanen</surname><given-names>H</given-names></name></person-group><article-title>Swelling of the upper extremity, function and muscle strength of shoulder joint following mastectomy combined with radiotherapy</article-title><source>Ann Clin Res</source><year>1978</year><volume>10</volume><fpage>273</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">104650</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornish</surname><given-names>BH</given-names></name><name><surname>Chapman</surname><given-names>M</given-names></name><name><surname>Hirst</surname><given-names>C</given-names></name><name><surname>Mirolo</surname><given-names>B</given-names></name><name><surname>Bunce</surname><given-names>IH</given-names></name><name><surname>Ward</surname><given-names>LC</given-names></name><name><surname>Thomas</surname><given-names>BJ</given-names></name></person-group><article-title>Early diagnosis of lymphedema using multiple frequency bioimpedance</article-title><source>Lymphology</source><year>2001</year><volume>34</volume><fpage>2</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11307661</pub-id></citation></ref><ref id="B23"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>E</given-names></name><name><surname>Roder</surname><given-names>D</given-names></name><name><surname>Bishop</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><source>Cancer in New South Wales: Incidence and mortality 2003</source><year>2005</year><publisher-name> NSW Central Cancer Registry, Cancer Institute NSW</publisher-name></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Husen</surname><given-names>M</given-names></name><name><surname>Paaschburg</surname><given-names>B</given-names></name><name><surname>Flyger</surname><given-names>HL</given-names></name></person-group><article-title>Two-step axillary operation increases risk of arm morbidity in breast cancer patients</article-title><source>Breast</source><year>2006</year><pub-id pub-id-type="pmid">16513350</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verhagen</surname><given-names>AP</given-names></name><name><surname>de Vet</surname><given-names>HC</given-names></name><name><surname>de Bie</surname><given-names>RA</given-names></name><name><surname>Kessels</surname><given-names>AG</given-names></name><name><surname>Boers</surname><given-names>M</given-names></name><name><surname>Bouter</surname><given-names>LM</given-names></name><name><surname>Knipschild</surname><given-names>PG</given-names></name></person-group><article-title>The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus</article-title><source>J Clin Epidemiol</source><year>1998</year><volume>51</volume><fpage>1235</fpage><lpage>1241</lpage><pub-id pub-id-type="pmid">10086815</pub-id><pub-id pub-id-type="doi">10.1016/S0895-4356(98)00131-0</pub-id></citation></ref></ref-list></back></article>